Your browser doesn't support javascript.
loading
2018 TSOC guideline focused update on diagnosis and treatment of pulmonary arterial hypertension.
Huang, Wei-Chun; Hsu, Chih-Hsin; Sung, Shih-Hsien; Ho, Wan-Jing; Chu, Chun-Yuan; Chang, Chih-Ping; Chiu, Yu-Wei; Wu, Chun-Hsien; Chang, Wei-Ting; Lin, Lin; Lin, Shoa-Lin; Cheng, Chin-Chang; Wu, Yih-Jer; Wu, Shu-Hao; Hsieh, Tsu-Yi; Hsu, Hsao-Hsun; Fu, Morgan; Dai, Zen-Kong; Kuo, Ping-Hung; Hwang, Juey-Jen; Cheng, Shu-Meng.
  • Huang WC; Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Physical Therapy, Fooyin University, Kaohsiung, Taiwan.
  • Hsu CH; Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
  • Sung SH; School of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Ho WJ; Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
  • Chu CY; Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Chang CP; Division of Cardiology, China Medical University Hospital, Taichung, Taiwan.
  • Chiu YW; Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
  • Wu CH; Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Chang WT; Division of Cardiovascular Medicine, Chi-Mei Medical Center, Tainan City, Taiwan.
  • Lin L; Cardiovascular Center, National Taiwan University Hospital, Hsinchu Branch, Hsinchu, Taiwan.
  • Lin SL; Department of Internal Medicine, Yuan's General Hospital, Kaohsiung, Taiwan.
  • Cheng CC; Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Physical Therapy, Fooyin University, Kaohsiung, Taiwan; Pulmonary Hypertension Center, Kaohsiung Veterans General Hospital, K
  • Wu YJ; Department of Medicine, Mackay Medical College, New Taipei City, Taiwan; Pulmonary Hypertension Interventional Medicine, Cardiovascular Center, Mackay Memorial Hospital, Taipei City, Taiwan.
  • Wu SH; Pulmonary Hypertension Interventional Medicine, Cardiovascular Center, Mackay Memorial Hospital, Taipei City, Taiwan.
  • Hsieh TY; Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Hsu HH; Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Fu M; Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
  • Dai ZK; Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Kuo PH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Hwang JJ; Cardiovascular Division, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan; National Taiwan University Hospital Yunlin Branch, Douliu City, Taiwan. Electronic address: jueyhwang@ntu.edu.tw.
  • Cheng SM; Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Electronic address: dmscmsc@yahoo.com.tw.
J Formos Med Assoc ; 118(12): 1584-1609, 2019 Dec.
Article en En | MEDLINE | ID: mdl-30926248
ABSTRACT
Pulmonary arterial hypertension (PAH) is characterized as a progressive and sustained increase in pulmonary vascular resistance, which may induce right ventricular failure. In 2014, the Working Group on Pulmonary Hypertension of the Taiwan Society of Cardiology (TSOC) conducted a review of data and developed a guideline for the management of PAH.4 In recent years, several advancements in diagnosis and treatment of PAH has occurred. Therefore, the Working Group on Pulmonary Hypertension of TSOC decided to come up with a focused update that addresses clinically important advances in PAH diagnosis and treatment. This 2018 focused update deals with (1) the role of echocardiography in PAH; (2) new diagnostic algorithm for the evaluation of PAH; (3) comprehensive prognostic evaluation and risk assessment; (4) treatment goals and follow-up strategy; (5) updated PAH targeted therapy; (6) combination therapy and goal-orientated therapy; (7) updated treatment for PAH associated with congenital heart disease; (8) updated treatment for PAH associated with connective tissue disease; and (9) updated treatment for chronic thromboembolic pulmonary hypertension.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Guías de Práctica Clínica como Asunto / Hipertensión Arterial Pulmonar Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Guías de Práctica Clínica como Asunto / Hipertensión Arterial Pulmonar Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article